Recombinant factor VIIa for intractable life-threatening bleeding in patients with circulatory assist devices.

Autoria(s): Schneider, A.G.; Perez, M.H.; Tozzi, P.; Voirol, P.; Schoettker, P.; Angelillo-Scherrer, A.; Cotting, J.; Von Segesser, L.; Eggimann, P.
Data(s)

01/09/2010
Identificador

https://serval.unil.ch/notice/serval:BIB_98A4B780B011

info:pmid:20521024

pmid:20521024

doi:10.1007/s00134-010-1937-y

isiid:000280908000028
Idioma(s)

eng
Fonte

Intensive care medicine3691620-1621
Tipo

info:eu-repo/semantics/article

article
Palavras-Chave #Adolescent; Adult; Assisted Circulation/adverse effects; Child; Coagulants/administration & dosage; Critical Care/methods; Factor VIIa/administration & dosage; Female; Humans; Infant; Intraoperative Complications/prevention & control; Male; Middle Aged; Postoperative Hemorrhage/drug therapy; Postoperative Hemorrhage/etiology; Recombinant Proteins/administration & dosage; Treatment Outcome
Acesso ao item digital